Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Abortion, Habitual D000026 5 associated lipids
Acidosis D000138 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agranulocytosis D000380 7 associated lipids
Airway Obstruction D000402 13 associated lipids
Albuminuria D000419 18 associated lipids
Alcoholic Intoxication D000435 15 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia D000740 21 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Schelzig H et al. Role of recombinant hirudin in a pig-to-human lung transplantation model. 2002 Transplant. Proc. pmid:12270449
Teraoka S et al. Multicenter trial of the therapeutic effect of a newly developed antiplatelet agent, satigrel, on biopsy-proven chronic rejection after kidney transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9122990
Ishine N et al. Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123045
Suehiro T et al. Value of caval effluent in predicting early graft function after orthotopic liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123086
Yagi T et al. Hepatropic soluble vitamin E derivative EPC-K1 prevents warm ischemia/reperfusion injury of non-heart-beating donor liver transplantation in pigs. 1997 Feb-Mar Transplant. Proc. pmid:9123352
Hashimoto T et al. Experimental study on the relationship between prostaglandin production and acute pancreatic rejection. 1989 Transplant. Proc. pmid:2495617
Jorkasky DK et al. The effects of cyclosporine on human platelet aggregation and thromboxane release. 1989 Transplant. Proc. pmid:2705264
López-Boado MA et al. Free radical ablation prevents ischemic injury after long periods of cold storage in rat pancreas transplantation. 1990 Transplant. Proc. pmid:2219357
Anderson CB et al. Thromboxane-B2 and renovascular resistance during hypothermic pulsatile perfusion. 1981 Transplant. Proc. pmid:7268892
Shimizu Y et al. Nafamostat mesilate prevents warm ischemia-reperfusion injury in canine pancreas autotransplantation. 1995 Transplant. Proc. pmid:8539906
Odor-Morales A et al. In vivo thromboxane production by different organs in the rat: its implication in organ transplant failure. 1987 Transplant. Proc. pmid:3617213
García-Valdecasas JC et al. Prostaglandin metabolism and hemodynamic alterations during human liver transplantation. 1993 Transplant. Proc. pmid:8470202
Uchiyama M et al. Comparison between nonpulsatile and pulsatile machine perfusion preservation in liver transplantation from non-heart-beating donors. 2001 Feb-Mar Transplant. Proc. pmid:11267136
Hoballah JJ et al. Lazaroid U74389G attenuates skeletal muscle reperfusion injury in a canine model. 1995 Transplant. Proc. pmid:7482936
Kasahara M et al. Effect of FK3311 on ischemia-reperfusion injury in canine pulmonary models. 2000 Transplant. Proc. pmid:11120230
Odor-Morales A et al. Increased thromboxane production by the pancreas after 24-hour preservation in UW-1 solution. 1991 Transplant. Proc. pmid:1989317
Kawai T et al. The changes in prostaglandins after segmental pancreatic transplantation. 1991 Transplant. Proc. pmid:1989318
Kin S et al. Effect of preservation on blood flow and production of prostacyclin and thromboxane A2 in canine segmental pancreatic autografts. 1991 Transplant. Proc. pmid:1989320
Quarto Di Palo F et al. Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide. 1991 Transplant. Proc. pmid:1989347
Foegh ML et al. Thromboxane and inflammatory cell infiltration of the allograft of renal transplant patients. 1987 Transplant. Proc. pmid:3313875
Santillan-Doherty P et al. Urinary thromboxane B2 excretion during acute rejection in cyclosporine-treated experimental lung allotransplantation. 1992 Transplant. Proc. pmid:1412957
Norio K et al. Eicosanoids and delayed graft function in human renal transplantation. 2001 Transplant. Proc. pmid:11406239
Saumweber DM et al. The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS. 1991 Transplant. Proc. pmid:1990613
Su CL et al. Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats. 2012 Transplant. Proc. pmid:22564588
van den Dorpel MA et al. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients. 1999 Feb-Mar Transplant. Proc. pmid:10083130
WÅ‚odarczyk Z et al. Effects of pentoxifylline treatment on delayed graft function in cadaveric kidney recipients. 2000 Transplant. Proc. pmid:10995988
Schultze G et al. Effect of cyclosporine on the generation of prostanoids by cultured peripheral lymphocytes. 1984 Transplant. Proc. pmid:6592863
Nakache R et al. Pancreatic juice immunoreactive thromboxane B2 in pancreas allograft rejection. 1990 Transplant. Proc. pmid:1691546
Odor-Morales A et al. Urinary amylase, urinary insulin, or urinary thromboxane: which is the best predictor of pancreatic allograft rejection in the dog? 1990 Transplant. Proc. pmid:1691549
Urade M et al. Changes of thromboxane B2 level in experimental orthotopic liver transplantation in swines--the effect of warm ischemia and thromboxane A2 synthetase inhibition. 1992 Transplant. Proc. pmid:1496677
Lim LK et al. Fine needle aspiration biopsy, serum beta 2-microglobulin, and urine thromboxane in renal allografts. 1989 Transplant. Proc. pmid:2669249
Odor-Morales A et al. Urinary thromboxane B2 as indicator of pancreatic allograft rejection in nonimmunosuppressed dogs. 1989 Transplant. Proc. pmid:2669272
Foegh ML et al. Urine thromboxane as an immunologic monitor in kidney transplant patients. 1984 Transplant. Proc. pmid:6390872
Foegh ML et al. Monitoring of rat heart allograft rejection by urinary thromboxane. 1984 Transplant. Proc. pmid:6390873
Saumweber DM et al. Studies on xenograft rejection: the role of leukocytes and prostaglandins and their modulation by the hetrazepine WEB 2086BS. 1992 Transplant. Proc. pmid:1566436
Pratschke J et al. Allogeneic heart transplantation following xenografting. 1992 Transplant. Proc. pmid:1566482
Sinzinger H et al. Platelet-derived growth factor and prostacyclin in kidney transplant rejection. 1987 Transplant. Proc. pmid:3303560
Elzinga L et al. Fish oil vehicle for cyclosporine lowers renal thromboxanes and reduces experimental nephrotoxicity. 1987 Transplant. Proc. pmid:3824502
Anderson C et al. Thromboxane synthesis inhibition and renal allograft function. 1989 Transplant. Proc. pmid:2650085
Pepino P et al. LTC4, thromboxane B2 and 6-keto PGF1 in syngeneic and allogenic heterotopic cardiac transplant in rats. 1989 Transplant. Proc. pmid:2650170
Seelos R et al. Prostaglandin synthesis and survival after orthotopic liver transplantation in pigs. 1991 Transplant. Proc. pmid:1926413
Iyobe T et al. Changes in prostaglandin levels in experimental liver transplantation in rats. 1994 Transplant. Proc. pmid:8066723
Kagawa K et al. Prolongation of rat cardiac allograft survival with arachidonic acid metabolism inhibitor. 1987 Transplant. Proc. pmid:3103286
Colomer J et al. Thromboxane flux and urinary eicosanoids as an index of reperfusion injury in pancreas transplantation after different periods of cold storage. 1988 Transplant. Proc. pmid:3055474
Foegh ML et al. Differential effect of CGS 13080, a thromboxane synthase inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients. 1988 Transplant. Proc. pmid:3279631
Pittet JF et al. Protective effect of indomethacin in the development of the postreperfusion syndrome during liver transplantation in pigs. 1991 Transplant. Proc. pmid:1871874
Quereda C et al. Urinary thromboxane B2 and cyclic AMP in cyclosporine-A-treated kidney transplantation. 1994 Transplant. Proc. pmid:7940810
Lim LK et al. Effect of the 5-lipoxygenase inhibitors EP 10045 and EP 10161 on cardiac graft cellular infiltrate and thromboxane formation. 1988 Transplant. Proc. pmid:3284052
Lim LK et al. Correlation of renal inflammatory cell infiltrate with thromboxane. 1988 Transplant. Proc. pmid:3284053
Häyry P et al. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection. 1993 Transplant. Proc. pmid:8438433